nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.125	0.309	CbGbCtD
Methotrimeprazine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0908	0.224	CbGbCtD
Methotrimeprazine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0726	0.179	CbGbCtD
Methotrimeprazine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0614	0.151	CbGbCtD
Methotrimeprazine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0355	0.0875	CbGbCtD
Methotrimeprazine—Necrotising colitis—Epirubicin—peripheral nervous system neoplasm	0.0208	0.0765	CcSEcCtD
Methotrimeprazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.02	0.0492	CbGbCtD
Methotrimeprazine—Necrotising colitis—Doxorubicin—peripheral nervous system neoplasm	0.0192	0.0707	CcSEcCtD
Methotrimeprazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.018	0.181	CbGeAlD
Methotrimeprazine—DRD5—ganglion—peripheral nervous system neoplasm	0.00798	0.0801	CbGeAlD
Methotrimeprazine—Drug interaction—Isotretinoin—peripheral nervous system neoplasm	0.00778	0.0286	CcSEcCtD
Methotrimeprazine—Drug interaction—Tretinoin—peripheral nervous system neoplasm	0.00778	0.0286	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Isotretinoin—peripheral nervous system neoplasm	0.00722	0.0266	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Tretinoin—peripheral nervous system neoplasm	0.00722	0.0266	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Melphalan—peripheral nervous system neoplasm	0.00713	0.0262	CcSEcCtD
Methotrimeprazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00659	0.0661	CbGeAlD
Methotrimeprazine—DRD1—nerve—peripheral nervous system neoplasm	0.00618	0.062	CbGeAlD
Methotrimeprazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00617	0.0619	CbGeAlD
Methotrimeprazine—DRD1—ganglion—peripheral nervous system neoplasm	0.0061	0.0612	CbGeAlD
Methotrimeprazine—Photosensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00597	0.022	CcSEcCtD
Methotrimeprazine—Photosensitivity—Tretinoin—peripheral nervous system neoplasm	0.00597	0.022	CcSEcCtD
Methotrimeprazine—Drug interaction—Alitretinoin—peripheral nervous system neoplasm	0.0059	0.0217	CcSEcCtD
Methotrimeprazine—Drug interaction—Vincristine—peripheral nervous system neoplasm	0.00568	0.0209	CcSEcCtD
Methotrimeprazine—Liver injury—Cisplatin—peripheral nervous system neoplasm	0.00554	0.0204	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Alitretinoin—peripheral nervous system neoplasm	0.00547	0.0201	CcSEcCtD
Methotrimeprazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00474	0.0476	CbGeAlD
Methotrimeprazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.0047	0.0471	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Cisplatin—peripheral nervous system neoplasm	0.00466	0.0172	CcSEcCtD
Methotrimeprazine—HTR2A—pons—peripheral nervous system neoplasm	0.00464	0.0466	CbGeAlD
Methotrimeprazine—Photosensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00452	0.0166	CcSEcCtD
Methotrimeprazine—Weight increased—Topotecan—peripheral nervous system neoplasm	0.00416	0.0153	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00414	0.0152	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00414	0.0152	CcSEcCtD
Methotrimeprazine—Weight increased—Isotretinoin—peripheral nervous system neoplasm	0.00412	0.0152	CcSEcCtD
Methotrimeprazine—Weight increased—Tretinoin—peripheral nervous system neoplasm	0.00412	0.0152	CcSEcCtD
Methotrimeprazine—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00404	0.0149	CcSEcCtD
Methotrimeprazine—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00404	0.0149	CcSEcCtD
Methotrimeprazine—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00389	0.0143	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00377	0.0139	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00377	0.0139	CcSEcCtD
Methotrimeprazine—DRD2—nerve—peripheral nervous system neoplasm	0.00365	0.0366	CbGeAlD
Methotrimeprazine—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.00364	0.0134	CcSEcCtD
Methotrimeprazine—DRD2—ganglion—peripheral nervous system neoplasm	0.0036	0.0362	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00313	0.0115	CcSEcCtD
Methotrimeprazine—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.0115	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.00309	0.0114	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00308	0.0113	CcSEcCtD
Methotrimeprazine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00306	0.0113	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00302	0.0111	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.0105	CcSEcCtD
Methotrimeprazine—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.00285	0.0105	CcSEcCtD
Methotrimeprazine—DRD1—brainstem—peripheral nervous system neoplasm	0.00265	0.0266	CbGeAlD
Methotrimeprazine—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.00969	CcSEcCtD
Methotrimeprazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00259	0.222	CrCbGaD
Methotrimeprazine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00925	CcSEcCtD
Methotrimeprazine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00925	CcSEcCtD
Methotrimeprazine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00248	0.00913	CcSEcCtD
Methotrimeprazine—HTR2A—nerve—peripheral nervous system neoplasm	0.00241	0.0242	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00239	0.00881	CcSEcCtD
Methotrimeprazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00238	0.0239	CbGeAlD
Methotrimeprazine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00233	0.00857	CcSEcCtD
Methotrimeprazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00229	0.00843	CcSEcCtD
Methotrimeprazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00229	0.00843	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00223	0.00821	CcSEcCtD
Methotrimeprazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00222	0.00817	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00222	0.00815	CcSEcCtD
Methotrimeprazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0022	0.00811	CcSEcCtD
Methotrimeprazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0022	0.00811	CcSEcCtD
Methotrimeprazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.00212	0.182	CrCbGaD
Methotrimeprazine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00207	0.0208	CbGeAlD
Methotrimeprazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00206	0.0207	CbGeAlD
Methotrimeprazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00729	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00191	0.00704	CcSEcCtD
Methotrimeprazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00701	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.00699	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0019	0.00699	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00187	0.00689	CcSEcCtD
Methotrimeprazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00674	CcSEcCtD
Methotrimeprazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.00639	CcSEcCtD
Methotrimeprazine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00172	0.0173	CbGeAlD
Methotrimeprazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.00614	CcSEcCtD
Methotrimeprazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00598	CcSEcCtD
Methotrimeprazine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00162	0.0163	CbGeAlD
Methotrimeprazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00161	0.00592	CcSEcCtD
Methotrimeprazine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.0016	0.016	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00584	CcSEcCtD
Methotrimeprazine—DRD2—brainstem—peripheral nervous system neoplasm	0.00157	0.0157	CbGeAlD
Methotrimeprazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00155	0.00571	CcSEcCtD
Methotrimeprazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00149	0.00547	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00541	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00529	CcSEcCtD
Methotrimeprazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.0014	0.014	CbGeAlD
Methotrimeprazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00139	0.0051	CcSEcCtD
Methotrimeprazine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00137	0.0138	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00505	CcSEcCtD
Methotrimeprazine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00503	CcSEcCtD
Methotrimeprazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00135	0.00499	CcSEcCtD
Methotrimeprazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00493	CcSEcCtD
Methotrimeprazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00481	CcSEcCtD
Methotrimeprazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.0013	0.0048	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00467	CcSEcCtD
Methotrimeprazine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00466	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00125	0.0046	CcSEcCtD
Methotrimeprazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00456	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00451	CcSEcCtD
Methotrimeprazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00445	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00426	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00112	0.00413	CcSEcCtD
Methotrimeprazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.00103	0.0104	CbGeAlD
Methotrimeprazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.00102	0.0877	CrCbGaD
Methotrimeprazine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000941	0.00945	CbGeAlD
Methotrimeprazine—Diltiazem—ABCB1—peripheral nervous system neoplasm	0.000932	0.0799	CrCbGaD
Methotrimeprazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000834	0.00307	CcSEcCtD
Methotrimeprazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.00083	0.0712	CrCbGaD
Methotrimeprazine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000788	0.00791	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000772	0.00775	CbGeAlD
Methotrimeprazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000772	0.00284	CcSEcCtD
Methotrimeprazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00076	0.0028	CcSEcCtD
Methotrimeprazine—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000751	0.00753	CbGeAlD
Methotrimeprazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000731	0.00269	CcSEcCtD
Methotrimeprazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000703	0.00259	CcSEcCtD
Methotrimeprazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000676	0.00249	CcSEcCtD
Methotrimeprazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000638	0.0548	CrCbGaD
Methotrimeprazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000629	0.00232	CcSEcCtD
Methotrimeprazine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000599	0.00601	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000586	0.00588	CbGeAlD
Methotrimeprazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000584	0.0501	CrCbGaD
Methotrimeprazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00214	CcSEcCtD
Methotrimeprazine—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000581	0.0499	CrCbGaD
Methotrimeprazine—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.000537	0.0461	CrCbGaD
Methotrimeprazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000517	0.0444	CrCbGaD
Methotrimeprazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.00051	0.0438	CrCbGaD
Methotrimeprazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000509	0.00511	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000464	0.00466	CbGeAlD
Methotrimeprazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.000401	0.0344	CrCbGaD
Methotrimeprazine—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000398	0.0342	CrCbGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.4e-05	0.000209	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.4e-05	0.000208	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	4.4e-05	0.000208	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.39e-05	0.000208	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.38e-05	0.000207	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.37e-05	0.000207	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.37e-05	0.000207	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.32e-05	0.000205	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.32e-05	0.000205	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.32e-05	0.000204	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.31e-05	0.000204	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	4.2e-05	0.000199	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.19e-05	0.000199	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.14e-05	0.000196	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.14e-05	0.000196	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.12e-05	0.000195	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.08e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.08e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	4.07e-05	0.000193	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.06e-05	0.000192	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.06e-05	0.000192	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.01e-05	0.00019	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	3.93e-05	0.000186	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.88e-05	0.000184	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.82e-05	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	3.78e-05	0.000179	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.74e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.73e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.67e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.62e-05	0.000171	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	3.61e-05	0.000171	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.59e-05	0.00017	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.57e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.52e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.49e-05	0.000165	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.47e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.45e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.43e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.43e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.42e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.41e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.37e-05	0.00016	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.36e-05	0.000159	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.31e-05	0.000157	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.29e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.28e-05	0.000155	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.27e-05	0.000155	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.26e-05	0.000154	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.24e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.24e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.22e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.21e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.21e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	3.19e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.17e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.13e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	3.12e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.12e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.11e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.11e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.1e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.1e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.09e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.07e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.06e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.06e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.06e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.05e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.05e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.04e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.03e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.03e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.03e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.01e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.98e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.97e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.96e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.94e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.94e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.92e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.92e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.9e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.85e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.84e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.83e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.79e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.78e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.75e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.73e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.73e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.71e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.71e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.71e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.67e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.67e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.67e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.66e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.65e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.63e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.62e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.6e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.6e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.56e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.55e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.53e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.53e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.51e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.48e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.48e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.46e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.46e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.44e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.44e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.44e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.42e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.42e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.42e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.41e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.41e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.41e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.41e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.4e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.37e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.37e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.32e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.32e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.31e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.28e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.28e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.28e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.27e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.27e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.26e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.24e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.23e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.23e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.22e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.22e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.21e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.21e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.2e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.2e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.19e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.18e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.18e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.18e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.16e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.15e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.12e-05	0.0001	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.1e-05	9.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.08e-05	9.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.07e-05	9.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.06e-05	9.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.06e-05	9.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.05e-05	9.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.03e-05	9.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.02e-05	9.55e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.01e-05	9.53e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.01e-05	9.53e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.01e-05	9.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2e-05	9.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2e-05	9.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2e-05	9.45e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.99e-05	9.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.99e-05	9.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.98e-05	9.36e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.97e-05	9.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.97e-05	9.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.92e-05	9.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.9e-05	9e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.89e-05	8.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.89e-05	8.95e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.87e-05	8.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.87e-05	8.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.87e-05	8.85e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-05	8.71e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-05	8.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.83e-05	8.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.83e-05	8.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.82e-05	8.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.81e-05	8.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.81e-05	8.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.8e-05	8.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.79e-05	8.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.79e-05	8.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.78e-05	8.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.75e-05	8.3e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.74e-05	8.25e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.71e-05	8.12e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.71e-05	8.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.7e-05	8.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.7e-05	8.05e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.69e-05	7.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.68e-05	7.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.68e-05	7.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.68e-05	7.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.67e-05	7.93e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.62e-05	7.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.61e-05	7.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.6e-05	7.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.58e-05	7.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.58e-05	7.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.58e-05	7.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.56e-05	7.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.55e-05	7.35e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.55e-05	7.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.51e-05	7.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.48e-05	7.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.43e-05	6.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.43e-05	6.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-05	6.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.41e-05	6.67e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.4e-05	6.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.4e-05	6.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.4e-05	6.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.38e-05	6.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.38e-05	6.53e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.37e-05	6.48e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.37e-05	6.48e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.35e-05	6.37e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.34e-05	6.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.34e-05	6.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.33e-05	6.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.33e-05	6.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.32e-05	6.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.32e-05	6.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.31e-05	6.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.29e-05	6.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.28e-05	6.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.22e-05	5.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.21e-05	5.72e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	5.63e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-05	5.62e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	5.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.18e-05	5.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.18e-05	5.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.17e-05	5.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.16e-05	5.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.08e-05	5.12e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	8.43e-06	3.99e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	7.14e-06	3.38e-05	CbGpPWpGaD
